Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous
Brand Name
K-phos
Generic Name
Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous
Active Ingredient
Potassium Phosphate, MonobasicCategory
Other
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 305 mg/1 | TABLET, COATED | ORAL | 0486-1134 |
Detailed information about K-phos
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for K-phos, you must consult a qualified healthcare professional.
Potassium Phosphate, Monobasic is a mineral supplement and urinary acidifier used to replenish phosphorus and potassium levels while managing urinary calcium levels. It is a critical electrolyte component for cellular energy and bone mineralization.
The dosage of Potassium Phosphate, Monobasic is highly individualized and must be based on the patient's serum electrolyte levels and the specific clinical indication. Dosage is often expressed in terms of millimoles (mmol) of phosphorus or milligrams (mg) of phosphorus.
Potassium Phosphate, Monobasic is used in pediatric populations but requires extreme caution due to the risk of metabolic imbalances.
Patients with impaired kidney function (reduced Glomerular Filtration Rate or GFR) require significant dose reductions. Because the kidneys are the primary route of elimination, even standard doses can lead to life-threatening hyperkalemia (high potassium) or hyperphosphatemia in these patients. In severe renal failure, the use of Potassium Phosphate, Monobasic is often contraindicated.
No specific dose adjustments are typically required for patients with liver disease, as the drug is not metabolized by the liver. However, these patients may have secondary renal issues (hepatorenal syndrome) that would necessitate caution.
Geriatric patients should be started at the lower end of the dosing range. This population is more likely to have undiagnosed age-related declines in renal function and may be taking other medications (like ACE inhibitors) that increase potassium levels.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this can cause a sudden, dangerous spike in potassium levels.
An overdose of Potassium Phosphate, Monobasic is a medical emergency. Signs of overdose include:
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance.
The most frequent side effects associated with oral Potassium Phosphate, Monobasic are gastrointestinal in nature. These occur because the salt can act as an osmotic laxative, drawing water into the intestines.
> Warning: Stop taking Potassium Phosphate, Monobasic and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of Potassium Phosphate, Monobasic requires careful monitoring for chronic complications:
There are currently no FDA black box warnings specifically for Potassium Phosphate, Monobasic. However, clinicians treat the risk of Hyperkalemia with the same level of gravity as a black box warning. In patients with severe renal impairment, the risk of fatal cardiac arrest from high potassium is so significant that the drug is considered contraindicated. Always ensure your doctor has a current list of all medications, especially 'water pills' (diuretics) or heart medications, which can exacerbate these risks.
Report any unusual symptoms to your healthcare provider. Regular blood tests (typically every 1–4 weeks during the start of therapy) are the only way to ensure these side effects are not occurring subclinically.
Potassium Phosphate, Monobasic is a potent electrolyte modifier. It should never be viewed as a simple 'vitamin supplement.' The margin between a therapeutic dose and a toxic dose can be narrow, especially in patients with underlying health conditions. The most critical safety concern is the maintenance of the delicate balance between potassium, phosphate, and calcium. An elevation in one often leads to a dangerous drop in another.
No FDA black box warnings for Potassium Phosphate, Monobasic. However, the FDA does require prominent warnings regarding the risk of hyperkalemia in all potassium-containing supplements, emphasizing that high blood potassium can lead to sudden, fatal cardiac arrhythmias without prior warning symptoms.
The most significant risk associated with this medication is the accumulation of potassium in the blood. This is particularly dangerous for patients with Addison's disease (adrenal insufficiency), severe burns, or those experiencing massive tissue breakdown (rhabdomyolysis), as these conditions already predispose the body to high potassium levels.
While used to prevent certain stones, in excess, this drug can cause nephrocalcinosis (calcium deposits in the kidneys). Patients with pre-existing kidney disease must be monitored with extreme frequency. If a patient develops a 'stone' while on therapy, it must be analyzed to ensure it is not a phosphate-based stone, which would require stopping the medication.
Patients with heart disease, particularly those with heart failure or a history of arrhythmias, are at higher risk for complications. Potassium levels must be kept within a very narrow range (usually 3.5 to 5.0 mEq/L) to prevent triggering dangerous heart rhythms.
As a urinary acidifier, this drug can contribute to systemic metabolic acidosis if taken in excessive quantities. This is a condition where the blood becomes too acidic, which can impair normal enzyme function and lead to fatigue, confusion, and rapid breathing.
Patients taking Potassium Phosphate, Monobasic must undergo regular laboratory testing. This typically includes:
Potassium Phosphate, Monobasic generally does not cause drowsiness or impair cognitive function. However, if a patient experiences dizziness or confusion due to electrolyte shifts, they should avoid driving or operating heavy machinery until their levels are stabilized and the symptoms resolve.
Alcohol should be used with caution. Chronic alcohol use can deplete phosphate levels (making the drug necessary) but can also impair kidney function and cause dehydration, which increases the risk of electrolyte toxicity. Furthermore, alcohol can irritate the stomach lining, potentially worsening the GI side effects of the medication.
Do not stop taking this medication suddenly if you are taking it for chronic hypophosphatemia, as your levels may drop rapidly. However, there is generally no 'withdrawal syndrome' associated with electrolyte supplements. If you need to stop the medication, your doctor will likely monitor your blood levels closely for several days afterward to ensure they remain stable.
> Important: Discuss all your medical conditions, especially kidney disease, heart disease, or thyroid problems, with your healthcare provider before starting Potassium Phosphate, Monobasic.
Drugs used for blood pressure like Lisinopril, Enalapril, Valsartan, and Losartan can increase potassium levels. When taken with Potassium Phosphate, Monobasic, the risk of hyperkalemia is significantly elevated. Doctors must monitor serum potassium levels frequently if these drugs are used together.
Potassium levels have a profound effect on the action of Digoxin. Both high and low potassium can increase the risk of Digoxin toxicity or reduce its effectiveness. Any patient on Digoxin starting a potassium-containing supplement requires intensive monitoring.
Non-steroidal anti-inflammatory drugs like Ibuprofen (Advil, Motrin) and Naproxen (Aleve) can reduce blood flow to the kidneys and decrease potassium excretion. Long-term use of high-dose NSAIDs with this supplement increases the risk of kidney strain and high potassium.
Calcitriol or other Vitamin D supplements increase the intestinal absorption of phosphate. Taking these with Potassium Phosphate, Monobasic can lead to hyperphosphatemia. The dose of one or both may need to be adjusted.
Calcium carbonate, calcium citrate, and antacids containing aluminum or magnesium (e.g., Maalox, Mylanta) can bind to phosphate in the gut. This creates an insoluble compound that cannot be absorbed. These should be taken at least 2 hours apart from the phosphate supplement.
Potassium Phosphate, Monobasic will directly affect blood and urine tests for:
For each major interaction, the mechanism is usually related to the renal handling of ions or intestinal absorption. The clinical consequence is typically an electrolyte imbalance that can affect heart rhythm or kidney health. Management involves frequent lab monitoring and dose titration.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers and antacids.
Potassium Phosphate, Monobasic must NEVER be used in the following conditions:
Conditions requiring a careful risk-benefit analysis by a physician:
While Potassium Phosphate, Monobasic is a simple mineral salt and does not have 'cross-allergies' in the way antibiotics do, patients who have had severe reactions to other potassium salts (like potassium chloride) or other phosphate salts (like sodium phosphate) should be monitored for similar gastrointestinal intolerance or sensitivity to the additives (like flavors or binders) in the specific formulation.
> Important: Your healthcare provider will evaluate your complete medical history, including your kidney function and current heart health, before prescribing Potassium Phosphate, Monobasic.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Potassium Phosphate, Monobasic in pregnant women. It is not known whether this medication can cause fetal harm when administered during pregnancy. However, maintaining normal phosphorus and potassium levels is essential for both maternal and fetal health.
Both potassium and phosphorus are natural components of human breast milk. When taken at therapeutic doses to correct a deficiency, it is unlikely to have an adverse effect on the nursing infant. However, high doses in the mother could theoretically shift the mineral balance of the milk. Nursing mothers should consult their pediatrician and have their own levels monitored to ensure they are within the normal range.
Potassium Phosphate, Monobasic is used in children for the treatment of rickets (bone weakening) and certain metabolic disorders. However, children are much more sensitive to rapid electrolyte shifts.
Patients over the age of 65 require special consideration:
This is the most critical special population. For patients with a GFR below 30 mL/min, Potassium Phosphate, Monobasic is generally avoided. For those with mild to moderate impairment (GFR 30-60 mL/min), doses must be reduced by at least 50%, and blood work should be performed weekly. In patients on dialysis, phosphate is usually something to be removed, not added, so this drug is rarely used unless the patient has a specific 'hungry bone syndrome' after surgery.
While the liver does not process this drug, patients with cirrhosis often have complex fluid balance issues. They may be on diuretics like Spironolactone, which makes potassium supplementation extremely dangerous. Dose adjustments are based on the patient's concurrent renal function and diuretic use rather than the severity of the liver disease itself.
> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring than the general population.
Potassium Phosphate, Monobasic acts as a dual-ion exogenous source of phosphorus and potassium.
| Parameter | Value |
|---|---|
| Bioavailability | 50% - 70% (Oral) |
| Protein Binding | Negligible |
| Half-life | 1 - 3 hours (Normal Renal Function) |
| Tmax | 1 - 2 hours (Oral) |
| Metabolism | None (Inorganic Salt) |
| Excretion | Renal (>90%), Fecal (Unabsorbed portion) |
Potassium Phosphate, Monobasic is classified as an Electrolyte/Mineral Supplement. Within the AHFS classification, it falls under 40:12 (Replacement Preparations). It is related to other phosphate salts like Sodium Phosphate and Dibasic Potassium Phosphate, but it is unique due to its higher acidity and lack of sodium, making it preferable for patients who must restrict sodium intake (e.g., those with congestive heart failure or hypertension).
Common questions about K-phos
Potassium Phosphate, Monobasic is primarily used as a source of phosphorus and potassium for patients who have a deficiency in these essential minerals, a condition known as hypophosphatemia. In addition to replenishment, it is frequently used as a urinary acidifier to lower the pH of urine, which can help prevent the formation of calcium-based kidney stones. By making the urine more acidic, it increases the solubility of calcium, stopping it from crystallizing into painful stones. Healthcare providers may also use it in hospital settings as part of intravenous nutrition for patients who cannot eat. It is a critical medication for maintaining energy production and proper heart function.
The most common side effects are related to the digestive system and include diarrhea, nausea, stomach cramps, and occasionally vomiting. These symptoms occur because the salt can draw water into the intestines, acting similarly to a mild laxative. Many patients find that taking the medication with a full glass of water and after a meal significantly reduces these uncomfortable effects. Some people may also notice a mild headache or a metallic taste in the mouth when they first start the medication. If diarrhea becomes severe or persistent, it is important to contact your doctor to prevent dehydration and further electrolyte imbalances.
It is generally advised to limit or avoid alcohol consumption while taking Potassium Phosphate, Monobasic. Alcohol can interfere with the way your kidneys process electrolytes and may lead to dehydration, which increases the risk of the supplement's levels becoming too high in your blood. Chronic alcohol use is also a common cause of low phosphate levels, so drinking may counteract the reason you are taking the supplement in the first place. Furthermore, alcohol can irritate the stomach lining, which may worsen the nausea or stomach pain caused by the medication. Always discuss your alcohol intake habits with your healthcare provider before starting this treatment.
Potassium Phosphate, Monobasic is classified as Pregnancy Category C, meaning there is limited research on its effects in pregnant women. While the minerals it provides are essential for the health of both the mother and the developing fetus, taking them in supplement form requires strict medical supervision. Excessive levels of phosphate can lead to low calcium levels in the mother, which could potentially affect fetal bone development. However, if a pregnant woman has a severe phosphate deficiency, the benefits of treatment may outweigh the potential risks. If you are pregnant or planning to become pregnant, your doctor will monitor your blood levels very closely to ensure the dose is safe.
When taken orally, Potassium Phosphate, Monobasic begins to be absorbed in the small intestine fairly quickly, with blood levels of potassium and phosphate starting to rise within 30 to 60 minutes. However, the 'visible' clinical effects, such as an increase in energy or a change in urine acidity, may take several days of consistent dosing to become apparent. For patients taking it to prevent kidney stones, the protective effect is ongoing as long as the medication is taken regularly. Your doctor will likely check your blood levels within the first week of therapy to ensure the medication is working effectively and that your levels are moving into the target range.
You should not stop taking Potassium Phosphate, Monobasic suddenly without first consulting your healthcare provider. If you are taking this medication to correct a chronic deficiency, stopping it abruptly could cause your phosphate or potassium levels to drop back down to dangerously low levels, leading to muscle weakness or heart rhythm issues. While there is no 'addiction' or traditional withdrawal associated with this mineral salt, the underlying condition being treated may return quickly. Your doctor will typically want to re-test your blood levels shortly after you stop the medication to ensure your body can maintain a healthy balance on its own.
If you miss a dose of Potassium Phosphate, Monobasic, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose entirely and continue with your regular dosing schedule. It is vital that you do not take two doses at once to make up for a missed one, as this can cause a sudden, dangerous spike in your potassium levels, which can affect your heart rhythm. To help you remember your doses, try taking the medication at the same time every day, such as with your main meals. If you miss multiple doses, contact your doctor for further instructions.
Potassium Phosphate, Monobasic does not typically cause an increase in body fat or traditional weight gain. However, some patients may experience mild fluid retention, which can show up as a slight increase on the scale or swelling in the ankles and feet. This happens because the salts can influence how the body holds onto water. If you notice rapid weight gain (more than 2-3 pounds in a day) or significant swelling, you should contact your doctor immediately, as this could be a sign that the medication is affecting your heart or kidney function. For most people, any weight change is minimal and related to fluid balance.
Potassium Phosphate, Monobasic has several significant drug interactions that require careful management. It should not be taken with potassium-sparing diuretics or certain blood pressure medications like ACE inhibitors, as these combinations can cause potassium to reach life-threatening levels. Additionally, antacids containing calcium, aluminum, or magnesium can bind to the phosphate and prevent it from being absorbed, so these should be taken at least two hours apart. Because of these and other potential interactions, it is crucial to provide your doctor and pharmacist with a complete list of all the medications, vitamins, and herbal supplements you are currently taking.
Yes, Potassium Phosphate, Monobasic is widely available as a generic medication, which is typically more cost-effective than brand-name versions. It is also a common ingredient in various 'buffered' phosphate supplements that contain a mix of different phosphate salts. Whether you are prescribed a brand name like K-Phos or a generic version, the active chemical ingredient remains the same. Generic versions must meet the same FDA standards for quality, strength, and purity as the brand-name products. Always check with your pharmacist to ensure you are receiving the specific salt form (monobasic) that your doctor has prescribed for your condition.
Other drugs with the same active ingredient (Potassium Phosphate, Monobasic)